Core Insights - Swiss drugmaker Novartis forecasts a decline in 2026 operating profit in the low single-digit percentage range due to competition from cheaper copies of established products [1] Company Summary - Novartis is facing challenges from generic competition which is expected to impact its operating profit negatively in the coming years [1]

Core Insights - Mercedes reported a 70% drop in operating profit in the third quarter, indicating significant financial challenges for the company [1] Financial Performance - The operating profit decline is attributed to the costs associated with job cuts, which have impacted the company's financial stability [1] - The company is also facing additional pressures from U.S. tariffs, which have further strained its profitability [1] - Weak demand for luxury vehicles has compounded these issues, leading to a challenging market environment for the German luxury carmaker [1]